Intuitive Surgical (ISRG) SVP logs PSU and RSU share vesting

Rhea-AI Filing Summary

Intuitive Surgical executive Iman Jeddi, SVP & GM da Vinci Platforms, reported the vesting and settlement of equity awards. Performance stock units granted in 2023 and restricted stock units granted in 2022 were converted into common shares, with portions of the resulting stock (311 and 4,155 shares at $503.51) withheld to cover tax obligations rather than sold in the open market. Following these transactions, Jeddi holds common stock directly and indirectly through a trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jeddi Iman

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & GM da Vinci Platforms &

3. Date of Earliest Transaction (Month/Day/Year)
02/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/28/2026		M(1)		626	A	$0.0	2,551(2)	D
Common Stock	02/28/2026		F(1)		311	D	$503.51	2,240(2)	D
Common Stock	02/28/2026		M(3)		8,378	A	$0.0	10,618(2)	D
Common Stock	02/28/2026		F(4)		4,155	D	$503.51	6,463(2)	D
Common Stock								26,649	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units - 2-28-2023	$0.0	02/28/2026		M			8,378	(3)	(3)	Common Stock	8,378	$0.0	0	D
Restricted Stock Units - 2-28-2022	$0.0	02/28/2026		M			626	(5)	(5)	Common Stock	626	$0.0	0	D

Explanation of Responses:

1. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

2. Includes 3 shares that should have been included on Form 3 filed Jan 29, 2026.

3. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

4. This transaction represents the withholding of shares to cover taxes applicable to a settlement of PSUs reported on this Form 4.

5. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

	By: Stephanie Lim-Ignacio For: Jeddi, Iman	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Intuitive Surgical (ISRG) executive Iman Jeddi report on this Form 4?

Iman Jeddi reported vesting and settlement of performance and restricted stock units that converted into Intuitive Surgical common shares. Some of the resulting shares were withheld to satisfy tax obligations, and updated direct and indirect ownership positions were disclosed.

How many performance stock units vested for Iman Jeddi at Intuitive Surgical (ISRG)?

Jeddi reported the exercise or conversion of 8,378 performance stock units initially granted on February 28, 2023. The filing notes that the compensation committee determined performance criteria were achieved and that these PSUs vest on February 28, 2026, subject to continued service.

What restricted stock unit activity did Intuitive Surgical (ISRG) disclose for Iman Jeddi?

The filing shows 626 restricted stock units from a February 28, 2022 grant converting into common stock. These RSUs vest 25% per year over four years, with shares released annually and a portion held back to cover statutory tax withholding requirements.

Were any of Iman Jeddi’s Intuitive Surgical (ISRG) shares sold on the open market?

The Form 4 indicates dispositions coded as “F,” representing shares withheld to pay taxes related to equity vesting at a price of $503.51 per share. This reflects tax-withholding transactions, not open-market sales initiated for investment purposes.

What is Iman Jeddi’s indirect ownership in Intuitive Surgical (ISRG) after these transactions?

The filing reports 26,649 shares of Intuitive Surgical common stock held indirectly by a trust associated with Jeddi. This position is reported as indirect ownership, separate from the directly held shares disclosed in the same Form 4.

How do Intuitive Surgical (ISRG) RSUs and PSUs for Iman Jeddi vest over time?

RSUs vest 25% per year over a four-year period starting on the first anniversary of grant, converting one-for-one into common stock. The PSUs reported vest on February 28, 2026, three years after grant, contingent on performance goals and continued service.